The Association between Gestational Diabetes and Non-alcoholic Fatty Liver Disease: Detection of Hepatic Steatosis and Fibrosis via FibroScan
Year: 2020
Type: dissertation
Study design: Observational Study
Abstract: Background: Non-alcoholic fatty liver disease (NAFLD) and gestational diabetes (GDM) are closely associated in pregnancy. Aim: To explore the antenatal relationships between FibroScan-detected NAFLD and GDM in a multiethnic population of pregnant women Methods: Pregnant women with GDM were recruited for a single FibroScan to determine cross-sectional prevalence of NAFLD. Furthermore, pregnant women without GDM but with risk factors for developing GDM were recruited in early pregnancy (<24/40 weeks gestation) for two sequential FibroScan assessment in early (<24/40 weeks) and late (>30/40 weeks) pregnancy, to explore the relationship between NAFLD and subsequent GDM status. Results: Of 108 women with GDM at 24-36 weeks gestation, 26.9% had evidence of NAFLD by FibroScan assessment. Women with NAFLD had a higher mean body mass index (BMI) than women without NAFLD. Of 55 women with identified risk factors for GDM at <24 weeks gestation, 14.5% had evidence of NAFLD by FibroScan assessment in early pregnancy. The cohort-wide GDM development rate was 25.5%. There was a trend towards a higher rate of developing GDM in women with evidence of NAFLD (28.6%) in early pregnancy compared to those without (9.8%), but this did not reach statistical significance. Of the 37 women who completed both FibroScan assessments, no cohort-wide changes were seen between scans in liver steatosis or liver fibrosis scores. Conclusion: There was a modest prevalence (26.9%) of NAFLD found by FibroScan assessment in women with GDM from our multiethnic cohort. However, women who had NAFLD detected in early pregnancy did not see a statistically significant increase in their subsequent rates of developing GDM compared to women without NAFLD. Increased maternal BMI was the strongest risk factor associated with NAFLD in both women with and without GDM. NAFLD in pregnant women, like GDM, may flag an increased risk profile in the antenatal period and in later life for T2DM and NAFLD progression.
Author: Difei Deng
Institution: The University of Sydney
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3121317372
